Browse drugs

…e, however, their lung function was normal post BDR.Conclusions FeNO is a powerful diagnostic tool with 78% of asthma diagnoses made…

…pb: 262 (57%)25–49 ppb: 110 (24%)≥50 ppb: 88 (19%)Patients with FeNO ≥50 ppb (19%) required no further testing in accordance with NI…

…mediate result which shows they may benefit from treatment with inhaled corticosteroids if they are symptomatic. Only 3.6% of patients were unable to p…

…nce and reliever therapy, were suggested. Patients liked use of FeNO to monitor changes in inflammation and assess the impact of man…

…risk of hospitalisation (OR=0.06,95%CI: 0.01–0.68, p=0.02) than FeNOHigh-AdhLow group(n=19). Regardless of adherence, no difference in the hosp…

…icult. Handheld spirometry and fractional exhaled nitric oxide (FeNO) are feasible for home use, enabling timely and flexible testin…

…acceptable and feasible.Conclusion Finger-prick, skin-prick and FeNO testing are conditionally acceptable and feasible in clinical p…

…al (>25 ppb). 54% of Asthma diagnosis could have been made with FeNO alone. (BTS, NICE, SIGN, 2024). 35% of patients with a definiti…

…ung people and leading to unnecessary treatments, in particular inhaled corticosteroids. Cardiopulmonary exercise testing (CPET) is an established obje…

…he 254 BDR tests performed, 24.4% were significant and 16.8% of FeNO tests were ≥50ppb. See table 1.Important Findings and Conclusio…

…n exploring functional gene profiling in relation to asthma and FeNO.…

…trol Questionnaire (ACQ-7) and fractional exhaled nitric oxide (FeNO) will also be assessed. The diagnostic performance of COLA-6 fo…